Neuroscience Experts from GSK, Eli Lilly and Janssen Meet in Search for Alzheimer’s Cure

Alzheimer’s GSK to provide a keynote address on delivering macromolecules across the blood brain barrier at Alzheimer’s industry meeting next May The GSK presentation will review challenges of macromolecule distribution and will ask the question: How can we measure CNS penetration? — SMi Group LONDON, ENGLAND, UNITED KINGDOM, March 22, 2016 /EINPresswire.com/ — SMi Group are delighted to have Steve Hood, Director of Biotransformation & Drug Deposition from GSK, present a keynote address at Alzheimers 2016 when it arrives to London on 10th & 11th May 2016.With a focus on small molecule drugs, the presentation will review challenges of macromolecule distribution and will ask the question: How can we measure CNS penetration? With collaborative research being a key emphasis of GSK, the European partnership “COMPACT” will also be introduced to…


Link to Full Article: Neuroscience Experts from GSK, Eli Lilly and Janssen Meet in Search for Alzheimer’s Cure